Australian and New Zealand consensus guideline for paediatric newly diagnosed immune thrombocytopaenia endorsed by Australian New Zealand Children's Haematology and Oncology Group

In children, the majority of cases are self‐limiting and thus many paediatric patients can be managed conservatively with minimal complications. This varies considerably compared to adult newly diagnosed immune thrombocytopaenia (NDITP) where, in most cases, thrombocytopaenia persists with higher ri...

Full description

Saved in:
Bibliographic Details
Published in:Journal of paediatrics and child health 2023-05, Vol.59 (5), p.711-717
Main Authors: Verissimo, Vanessa, Carter, Tina, Wright, Helen, Robertson, Jeremy, Osborn, Michael, Bradbeer, Peter, Sabesan, Vanaja, Saxon, Ben, Barbaro, Pasquale, Crighton, Gemma, Chamberlain, Janis, Zheng, Silvia, Freeman, Kate
Format: Article
Language:English
Subjects:
Adult
Australia
bleeding risk
Child
Hematology - standards
Humans
immune thrombocytopaenia
management
New Zealand
paediatrics
Pediatrics
Practice Guidelines as Topic
Purpura, Thrombocytopenic, Idiopathic - diagnosis
Purpura, Thrombocytopenic, Idiopathic - therapy
treatment
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In children, the majority of cases are self‐limiting and thus many paediatric patients can be managed conservatively with minimal complications. This varies considerably compared to adult newly diagnosed immune thrombocytopaenia (NDITP) where, in most cases, thrombocytopaenia persists with higher risk of moderate to severe bleeding complications. In the past decade, local and international guidelines have emerged to support approaches to the investigation and management of NDITP, with a focus primarily on adult immune thrombocytopaenia (ITP). International consensus guidelines on paediatric NDITP have been developed, however gaps remain, and approaches vary between North American, Asia, Europe and the UK. There are no current Australian or New Zealand paediatric ITP guidelines readily available, rather differing guidelines for each state, territory or island. These inconsistencies cause uncertainty for patients, families and physicians managing cases. Subsequently, physicians, including paediatric haematologists and general paediatricians, have come together to provide a consensus approach guideline specific to paediatric NDITP for Australian or New Zealand. Persistent or chronic paediatric ITP remains a complex and separate entity and are not discussed here.
ISSN:1034-4810
1440-1754
DOI:10.1111/jpc.16395